Australia markets closed

NewAmsterdam Pharma Company N.V. (NAMS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
20.09+0.04 (+0.20%)
At close: 04:00PM EDT
20.09 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts7777
Avg. Estimate-0.59-0.53-2.56-1.79
Low estimate-0.65-0.59-2.85-2.39
High estimate-0.51-0.44-1.92-1.17
Year ago EPSN/A-0.54-2.15-2.56
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6676
Avg. Estimate1.38M2.43M9.91M3M
Low estimateN/AN/AN/AN/A
High estimate3.3M8.7M28.9M9.9M
Year ago salesN/A2.89M14.09M9.91M
Sales growth (year/est)N/A-16.00%-29.70%-69.70%
Earnings historyInvalid Date29/09/202330/12/202330/03/2024
Est. EPSN/A-0.49-0.6-0.53
Actual EPSN/A-0.54-0.58-1.06
DifferenceN/A-0.050.02-0.53
Surprise %N/A-10.20%3.30%-100.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.59-0.53-2.56-1.79
7 days ago-0.53-0.46-6.75-5.12
30 days ago-0.53-0.46-1.92-1.57
60 days ago-0.53-0.45-1.87-1.5
90 days ago-0.54-0.48-1.96-1.61
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 days5555
Growth estimatesNAMSIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.1.90%N/AN/AN/A
Current year-19.10%N/AN/AN/A
Next year30.10%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A